(b)(6).The actual device was not available; however, a video and photograph of the sample were provided for evaluation.The returned video and photograph were reviewed, and it was noted that there was a leak from the effluent pod.The reported condition was verified.The cause of the reported condition could not be determined.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.Prismaflex st150 set c has been temporarily approved for use in the us under emergency use authorization eua (b)(4) to deliver crrt to treat patients in an acute care environment during the covid-19 pandemic.
|